Biden nominee for head of HHS gets Senate backing, just

19 March 2021
xavier_becerra_big

US Senators on Thursday approved California Attorney General Xavier Becerra as Health and Human Services (HHS) Secretary on a razor-thin vote that broke almost entirely along party lines and followed searing debate over the lawyer's qualifications and support for abortion rights.

US President Joe Biden's nominee to lead the powerful HHS had a tough ride through the Senate in the first of two hearings, with Republicans portraying Mr Becerra as unfit.

The department includes agencies at the core of the federal response to the pandemic that has infected more than 29.6 million people in the United States and killed more than 535,000, commented the Washington Post. They include the National Institutes of Health, the Centers for Disease Control and Prevention, the vaccine-approving Food and Drug Administration, which is currently headed by Dr Janet Woodcock as Acting Commissioner, and the Centers for Medicare and Medicaid Services, which oversees the country’s vast public insurance programs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical